Literature DB >> 25855403

Pancreatic cancer: A matter of timing.

Sarah Seton-Rogers.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25855403     DOI： 10.1038/nrc3948

Source DB:  PubMed          Journal:  Nat Rev Cancer        ISSN： 1474-175X            Impact factor:   60.716


× No keyword cloud information.
  1 in total

1.  Brg1 promotes both tumor-suppressive and oncogenic activities at distinct stages of pancreatic cancer formation.

Authors:  Nilotpal Roy; Shivani Malik; Karina E Villanueva; Atsushi Urano; Xinyuan Lu; Guido Von Figura; E Scott Seeley; David W Dawson; Eric A Collisson; Matthias Hebrok
Journal:  Genes Dev       Date:  2015-03-15       Impact factor: 11.361
  1 in total
  1 in total

1.  Gemcitabine exhibits a suppressive effect on pancreatic cancer cell growth by regulating processing of PVT1 to miR1207.

Authors:  Lei You; Huanyu Wang; Gang Yang; Fangyu Zhao; Jingcheng Zhang; Ziwen Liu; Taiping Zhang; Zhiyong Liang; Changzheng Liu; Yupei Zhao
Journal:  Mol Oncol       Date:  2018-10-30       Impact factor: 6.603
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.